Insider · CIK 0001239546

BOYER ANDREW S

Reports to the SEC for 2 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001239546

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	AMRXAmneal Pharmaceuticals, Inc.G Gift	Executive Vice President	GGift	−80K sh	—	—	193,646
2026-08-21	AMRXAmneal Pharmaceuticals, Inc.G Gift	Executive Vice President	GGift	−152K sh	—	—	273,646
2026-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−38.2K sh	—	—	76,389
2026-03-04	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−19.1K sh	$13.30	−$255K	426,072
2026-03-04	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+38.2K sh	—	—	445,208
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−19.9K sh	$13.31	−$265K	171,733
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−398K sh	—	—	0
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+24.3K sh	—	—	220,788
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+398K sh	—	—	606,188
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+49.7K sh	—	—	221,427
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−24.3K sh	—	—	72,774
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−24.9K sh	$13.31	−$331K	196,530
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+39.3K sh	—	—	191,678
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−49.7K sh	—	—	49,695
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−39.3K sh	—	—	0
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−12.2K sh	$13.31	−$162K	208,634
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−199K sh	$13.31	−$2.65M	407,013
2026-03-02	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Executive Vice President	AAward	+65.4K sh	—	—	65,359
2026-03-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Executive Vice President	AAward	+65.4K sh	—	—	65,359
2025-08-20	AMRXAmneal Pharmaceuticals, Inc.S Sale	Executive Vice President	SSale	−279K sh	$9.38	−$2.62M	152,426
2025-08-20	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+175K sh	$2.75	+$481K	431,670
2025-08-20	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−175K sh	—	—	97,480
2025-08-12	AMRXAmneal Pharmaceuticals, Inc.S Sale	Executive Vice President	SSale	−33.4K sh	$9.05	−$303K	256,670
2025-03-05	AMRXAmneal Pharmaceuticals, Inc.S Sale	Executive Vice President	SSale	−125K sh	$8.89	−$1.11M	290,106
2025-03-04	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+38.2K sh	—	—	434,643
2025-03-04	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−19.5K sh	$8.84	−$173K	415,106
2025-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−38.2K sh	—	—	114,582
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−157K sh	—	—	0
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+157K sh	—	—	476,758
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−80.3K sh	$8.76	−$704K	396,449
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Executive Vice President	AAward	+194K sh	—	—	194,064
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Executive Vice President	AAward	+97K sh	—	—	97,033
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+49.7K sh	—	—	345,172
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−49.7K sh	—	—	99,389
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−20.1K sh	$8.76	−$176K	295,478
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−25.4K sh	$8.76	−$223K	319,753
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+39.3K sh	—	—	315,555
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−39.3K sh	—	—	39,252
2025-03-01	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−11.7K sh	$8.67	−$102K	276,304
2025-03-01	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−31.4K sh	—	—	0
2025-03-01	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+31.4K sh	—	—	288,041
2024-08-15	AMRXAmneal Pharmaceuticals, Inc.S Sale	Executive Vice President	SSale	−40.2K sh	$7.85	−$316K	256,670
2024-08-14	AMRXAmneal Pharmaceuticals, Inc.S Sale	Executive Vice President	SSale	−22.5K sh	$7.81	−$176K	296,895
2024-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Executive Vice President	AAward	+153K sh	—	—	152,778
2024-03-04	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Executive Vice President	AAward	+306K sh	—	—	305,556
2024-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−39.3K sh	—	—	78,503
2024-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+39.3K sh	—	—	314,249
2024-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−19.7K sh	$5.47	−$108K	294,584
2024-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+49.7K sh	—	—	344,278
2024-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−49.7K sh	—	—	149,083

Recent filings

Accepted (ET)
Sep 24
BOYER ANDREW S0001628280-26-060179
SEC(opens sec.gov)
Aug 254
BOYER ANDREW S0001628280-26-058918
SEC(opens sec.gov)
Mar 54
BOYER ANDREW S0001628280-26-015238
SEC(opens sec.gov)
Mar 34
BOYER ANDREW S0001628280-26-013878
SEC(opens sec.gov)
Aug 224
BOYER ANDREW S0001628280-25-041033
SEC(opens sec.gov)

Companies

Address

C/O AMNEAL PHARMACEUTICALS, INC.

BRIDGEWATER, NJ, 08807